Hospitals could be without tocilizumab, one of the only therapies for Covid-19 patients cleared for use in the U.S., for weeks and the World Health Organization urged maker Roche to ensure it is distributed fairly around the world.
Leaving some countries without access to vaccines while others hoard supplies could prolong the pandemic, researchers warned, and bring about more transmissible variants capable of escaping the immunity offered by vaccination and infection.